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Abstract
Background: In genomics, hierarchical clustering (HC) is a popular method for grouping similar samples based on a
distance measure. HC algorithms do not actually create clusters, but compute a hierarchical representation of the data
set. Usually, a fixed height on the HC tree is used, and each contiguous branch of samples below that height is
considered a separate cluster. Due to the fixed-height cutting, those clusters may not unravel significant functional
coherence hidden deeper in the tree. Besides that, most existing approaches do not make use of available clinical
information to guide cluster extraction from the HC. Thus, the identified subgroups may be difficult to interpret in
relation to that information.
Results: We develop a novel framework for decomposing the HC tree into clusters by semi-supervised piecewise
snipping. The framework, called guided piecewise snipping, utilizes both molecular data and clinical information to
decompose the HC tree into clusters. It cuts the given HC tree at variable heights to find a partition (a set of
non-overlapping clusters) which does not only represent a structure deemed to underlie the data from which HC tree
is derived, but is also maximally consistent with the supplied clinical data. Moreover, the approach does not require
the user to specify the number of clusters prior to the analysis. Extensive results on simulated and multiple medical
data sets show that our approach consistently produces more meaningful clusters than the standard fixed-height cut
and/or non-guided approaches.
Conclusions: The guided piecewise snipping approach features several novelties and advantages over existing
approaches. The proposed algorithm is generic, and can be combined with other algorithms that operate on
detected clusters. This approach represents an advancement in several regards: (1) a piecewise tree snipping
framework that efficiently extracts clusters by snipping the HC tree possibly at variable heights while preserving the
HC tree structure; (2) a flexible implementation allowing a variety of data types for both building and snipping the HC
tree, including patient follow-up data like survival as auxiliary information.
The data sets and R code are provided as supplementary files. The proposed method is available from Bioconductor as
the R-package HCsnip.
Background
Hierarchical clustering (HC) is a popular data mining
technique for detecting clusters of closely related objects
in data, and is widely used in computational biology for
the analysis of microarray data, DNA copy number data,
phylogeny, and others. More than 90% of published clus-
tering applications to microarray data use the HC [1].
Popularity of the HC is largely due to its robustness to the
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shape of clusters and the ability to represent nested clus-
ters. The HC organizes objects into a hierarchical cluster
tree (dendrogram) with branches that represent potential
clusters. However, the HC algorithms do not actually par-
tition the given data set into clusters, but only compute a
hierarchical representation of the data. A HC tree derived
from molecular data expresses the tendency of samples
to be clustered by their molecular signatures. The HC
has been used to identify clinically relevant cancer sub-
types in several studies [2-5]. The focus of this study is
placed on identifying clusters of patients that are located
deep in the HC tree with distinct clinical outcomes. We
© 2015 Obulkasim et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Obulkasim et al. BMC Bioinformatics  (2015) 16:15 Page 2 of 11
achieve this goal by using high-dimensional molecular
data augmented by additional clinical information.
Since there are no explicit clusters in the HC output,
clusters are obtained either manually by visually inspect-
ing the tree structure or by cutting theHC tree at a specific
height, after which the resulting connected components
are treated as clusters. The latter (referred as the fixed-
height cut hereafter) is a simple, yet elegant technique
commonly used in practice. However, extracting clusters
via the fixed-height cut comes at a cost. As noted in sev-
eral studies [4,6,7], it may fail to extract the nested clusters
in the HC tree (see Additional file 1: Figure S1). With-
out losing the advantages the HC enjoys, alleviating the
problems of the fixed-height cut approach is the focus of
this paper. A second disadvantage of most unsupervised
learning methods is that identified clusters (cancer molec-
ular subtypes) are unrelated to patient clinical information
[8]. Since the HC does not utilize the available clinical
data, there is no guarantee that the identified subtypes will
exhibit significant functional coherence.
We propose a novel procedure to extract clusters from
the HC tree, called guided piecewise snipping. Our
method resolves the drawbacks of the standard fixed-
height cut approach by allowing the piecewise rather than
the fixed-height cut, and incorporating available clinical
data to decide upon the optimal cut. It snips the given
HC tree (possibly) at different heights to ensure a) a high
score for cluster homogeneity; and b) a high score for con-
sistency with the clinical data used for guidance. Hence,
the optimal partition is the one ranked high by both data
types. Note that the co-use of clinical data for evaluat-
ing a partition helps to make the clustering more robust,
a major concern when dealing with high-dimensional
molecular data.
Let us now illustrate some of the drawbacks of, first,
fixed-height cuts and, second, unguided clustering eval-
uation. We use the Lung.1 gene expression data set [5]
(Table 1) for which patient follow-up information is also
available. A HC tree with Pearson correlation as similarity
metric and Ward [9] linkage is derived using the expres-
sion data (Figure 1). The complete set of partitions, where
a partition (clustering) is composed of non-overlapping
clusters, is extracted by cutting (with a straight line) the
HC tree at all possible heights. To assess the quality of
a partition, the Cox model is used to quantify the asso-
ciation between cluster labels in the partition and the
patient survival time. Then, the likelihood and the Akaike
information criterion (AIC) are obtained. The optimal
partition induced by the fixed-height cut (AIC = 177)
is composed of two clusters (s.cluster1-2). For illustration
purposes, we keep the s.cluster2 fixed, and decompose the
s.cluster1 (by piecewise snipping) into two sub-clusters
Figure 1 The HC tree corresponds to the Lung.1 data set, and the optimal cuts induced by the two approaches. The fixed-height cut
approach produces the the HC tree into two clusters (fixed-height.cluster1-2). The piecewise snipping, on the other hand, renders three clusters by
splitting the fixed-height.cluster1 into two sub-clusters (piecewise.cluster1-2).
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Table 1 Data set summaries
Cancer type Reference # Samples (feat.) Data type
Lung.1 Beer(2002) 86(7129) mRNA
Leukemia Bullinger(2004) 116(6283) mRNA
Lung.2 Bhattacharjee(2001) 125(3171) mRNA
Lymphoma Rosenwald(2002) 240(7399) mRNA
Prostate Sboner(2010) 281(6100) mRNA
Glioblastoma Verhaak(2010) 158(10850) DNA
Time-to-death follow-up information is available for all data sets except for the Leukemia data set for which follow-up data is time-to-relapse.
p.cluster1-2. The new partition decreases the AIC to 166.
In addition, patients in the p.cluster1-2 manifest very dif-
ferent survival outcomes (logrank test p-value = 0.04).
This shows that there are clinically heterogeneous clusters
on the left branch of the HC left branch of the HC tree
that are forced to merge by the fixed-height cut (Figure 2).
A simulation study also confirms the limitations of the
fixed-height cut (see further on and the Additional file 1).
Next, we apply one of the well-known unguided cluster-
ing algorithms, Dynamic Tree Cut [6] to the HC tree in
Figure 1. The algorithm decomposes the HC tree into 13
clusters (Additional file 1: Figure S2) that renders AIC =
204. Clearly, lack of guidance leads to unnecessary splits
(merges) of the clusters. Often, clinical data is also avail-
able, and may be used to “guide” or “adjust” the process of
clustering.
Semi-supervised clustering approaches to integrate
prior biological knowledge into the clustering procedure
have added much to endeavor [10,11]. Many algorithms
have been proposed to exploit the domain knowledge and
to improve cluster relevance, with significant improve-
ments over their unsupervised counterparts [8,12]. Some
studies used model-based integration approaches to
explicitly model the joint probability of gene expres-
sion and functional labels of genes. Other studies pro-
posed to modify the distance between expression profiles
prior to the HC tree construction. These modifica-
tions usually produce different clustering results from
the ones produced solely on the basis of the samples’
molecular profiles. To our knowledge, so far only two
approaches have been proposed to snip the HC tree at
variable heights. One is a HC tree snipping method spe-
cific for gene clustering only. It snips the tree branches
at different heights to induce clusters that are maxi-
mally consistent with partially available gene labels [10].
Another one is a semi-supervised approach, called VI-
cut, that has been proposed to decompose a HC tree
into clusters that optimally match a set of known anno-
tations [13]. These approaches are, however, not without
problems. For example, the former is designed for gene
Figure 2 Survival curves correspond to the clusters formed on the left branch of the HC tree in Figure 1.
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clustering; application to sample clustering application is
not straightforward, because “clustering samples is very
different to clustering genes” [14]. The second one only
allows gene expression data. Besides that, both require the
auxiliary information in discrete format, i.e. class labels of
the samples, which limits these methods’ utilities in fully
exploiting the HC tree structure. It is desirable to have a
procedure that is applicable to a wide variety of data types.
Continuous-scaled patient clinical data, such as survival
times, is often available [2,3]. One could discretize these,
but this comes at a cost of losing information [15].
Guided piecewise snipping enjoys the following three
advantages over existing approaches. First, any type of
clinical data can be used to “guide” the tree snipping
process, no discretization is needed. Second, the optimal
partition will be selected on the basis of its quality in
both data spaces, which makes the result more stable and
easy to interpret. Third, our algorithm uniquely applies a
molecular to follow-up projection principle when assign-
ing test samples (for which the follow-up data is unknown)
to one of the existing clusters. While the guided piece-
wise snipping approach proposed in this paper can accept
many types of input, we focus in our examples on the
case where the given two data types are high-dimensional
molecular data and (possibly censored) time-to-event data
(i.e. survival, remission, tumor recurrence) throughout
(see Discussion).
Results
Performance comparisons of the two approaches are con-
ducted usingmultiplemedical data sets. Before presenting
experimental results, we first summarize these data sets.
Additional results are given in the Additional file 1.
Data
A summary of five publicly available gene expression data
sets with time-to-event information used in this study is
given in Table 1. To show the generality, a DNA copy
number data set is also included.
Comparison
For the data sets above, performance of the guided piece-
wise snipping was compared with a)unguided piecewise
snipping, which makes no use of survival data; and b)
guided and unguided fixed-height cuts. The unguided
procedures use only WSS as evaluation criterion on
the clustering. In addition, we assess whether test label
assignment to the clusters by our novel PNNC-distance
improves assignment based on by Ward-distance. The
quality of the partitions is assessed by the statistical testing
procedure described above. We report the median log-
rank p-value over the three folds of the cross-validation
in Table 2. In addition, we report the global test [16] p-
value, which quantifies the overall association between the
molecular and time-to-event data in the entire data set.
If such a p-value is small, one expects a more beneficial
effect of guidance than when it is large.
From Table 2 it is clear that in most of the data sets the
piecewise snipping approaches outperform their fixed-
height cut counterparts, in particular when guidance is
used. In addition, the guided piecewise snipping clearly
outperforms the unguided piecewise snipping when the
global test indicates a strong association between the
two data types. Finally, the test label assignment by the
novel PNNC-distance results in a smaller log-rank p-
value than the corresponding one of the assignment by
Ward for 4/6 data sets, indicating the potential benefit of
PNNC.
Visualization
To assist in visual inspection of the differences between
the clusters induced by the two approaches, we summa-
rize clusters in terms of 1) time-to-event information;
patients’ follow-up information in each cluster is used to
construct the Kaplan-Meier survival curve. 2) molecular
profiles of the samples; summarized bymolecular entropy,
as a measure of overall expressions [17]. Here, we present
the results for the Leukemia data, using the BIC + GK
criterion for partition evaluation.
Figure 3 shows the derived HC tree, and the cuts
induced by the two approaches. The fixed-height
cut approach generates a partition with two clusters
(s.cluster), while the guided piecewise snipping iden-
tifies six clusters (p.cluster). The latter splits the two
big clusters (s.cluster1-2) into sub-clusters with different
sizes. The survival curves associated with the s.cluster1
and p.cluster1-3 on the left branch of the HC tree are
shown in Figure 4. The three sub-clusters turn out to
contain patients with relatively different clinical out-
comes (p-value = 0.11). Cluster p.cluster1 corresponds
to the medium good-prognosis group with 29% patients
(4/14) who experienced relapse, p.cluster2 corresponds to
the good-prognosis group containing 14% (1/7) relapsed
patients, and p.cluster3 corresponds to the poor-prognosis
group in which 58% (11/19) of patients experienced
relapse of the tumor. Violin plots of cluster entropies
(Additional file 1: Figure S7) further show that molecular
profiles are also different in these three clusters.
The same phenomenon is observed on the right branch
of the HC tree. The standard approach again merges
all patients in this branch into one cluster, but five
sub-clusters are identified by our approach. Observe in
Figure 5 that, these five clusters are also manifest clinically
different characteristics (p-value = 0.05a). In particular,
note p.cluster6; it is hidden rather deeply in the tree, but
has the worst survival, much worse than its neighbors e.g.
p.cluster5. Entropy distributions in these clusters are also
support this observed differences (see Additional file 1:
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Table 2 Comparison of a) unguided fixed-height cuts; b) guided fixed-height cuts; c) unguided piecewise snipping; d)
guided piecewise snipping; e) guided piecewise snipping + PNNC
Data Fixed-height cut Piecewise snipping
Unguided Guided Unguided Guided Guided
Ward Ward Ward Ward PNNC Global test
Lung.1 0.394 0.167 0.308 0.071 0.016 0.019
Leukemia 0.688 0.238 0.336 0.016 0.002 0.004
Lung.2 0.256 0.497 0.418 0.103 0.048 0.227
Lymphoma 0.149 0.113 0.176 0.038 0.001 0.001
Prostate 0.086 0.360 0.091 0.083 0.107 0.002
Glioblastoma 0.142 0.160 0.064 0.041 0.103 0.003
All guided approaches useWSS + AIC as cluster evaluation criterion, the unguided approaches use WSS only; a)-d) useWard distance for test sample assignment,
whereas e) uses PNNC. The first five numeric columns contain the median log-rank p-values across the three splits of the 3-fold CV. The last column contains the
p-values from the global test for overall association between the molecular and time-to-event data.
Figure S7). Especially, the average entropy of p.cluster6 is
considerably higher than the rest.
We also examine the association between the optimal
partitions found by the two approaches in the Lung.1 data
set and that of the clinical outcomes, Differentiation and
Stage, not used in the cluster extraction process. In partic-
ular, Stage has stronger association with the guided piece-
wise snipping induced partition than the one from the
fixed-height cut, which shows that the former is poten-
tially also more relevant for outcomes other than survival
(see Table S3).
Illustrations for the other data sets are given in the
Additional file 1. While for most of the data sets guided
piecewise snipping renders clusters substantially differ-
ent from those from the fixed-height cut, there are some
cases in which two approaches produce similar results
(see Additional file 1: Figure S15).
Simulation results
We also performed a simulation study, which serves
to illustrate the effect of cluster heterogeneity on the
performance of both fixed-height cutting and piecewise
Figure 3 TheHC tree corresponds to the Leukemia data set, and the optimal cuts induced by the two approaches.While, the fixed-height cut
decomposes the HC tree into two big clusters (fixed-height.cluster1-2), eight clusters (piecewise.cluster1-8) are produced by the piecewise snipping.
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Figure 4 The survival curves correspond to clusters on the left branch of the HC tree in Figure 3.
snipping and to compare the two. In this simulation we do
not involve follow-up information, because the potential
use of clinical follow-up to improve the cluster results was
already demonstrated for several real data sets (see Table
2). In addition, follow-up information is not necessary to
demonstrate that, as opposed to piecewise snipping the
fixed-height cut may sometimes not capture true clus-
ters (known from the simulation setting) that are hidden
deeply in the HC tree.
The Additional file 1 contains a complete description
of the simulation and its results. Here, we provide a
summary. We studied three scenarios. Expression data
are simulated from a multivariate Normal mixture dis-
tribution, where the mixture components represent the
clusters. The overlap between the components quanti-
fies the cluster heterogeneity: the larger the overlap, the
more difficult the extraction of the clusters from the HC
tree that is generated from the simulated data. For three
Figure 5 The survival curves correspond to the clusters on the right branch of the HC tree in Figure 3.
Obulkasim et al. BMC Bioinformatics  (2015) 16:15 Page 7 of 11
scenarios with increasing cluster heterogeneity Additional
file 1: Figures S2 to S4 show the resulting HC trees and
the true cluster labels of each of the simulated samples.
The fixed-height cut and the piecewise snipping were
applied to the HC tree using WSS as evaluation criterion.
The two algorithms are compared by the Adjusted Rand
Index (ARI), which is a standard metric for measuring the
overlap between the true clustering and the data-driven
one.
The simulation study shows that if the true clusters
are homogeneous and well-separated (Scenario 1), both
fixed-height cutting and piecewise snipping perform well
(Additional file 1: Figure S2). Still the ARI of piecewise
snipping is somewhat better (1 vs 0.93), because it better
discerns true cluster 4 from 3. For scenario 2, with inter-
mediate level of cluster heterogeneity, piecewise snipping
clearly outperforms fixed-height cutting, ARI = 0.46 vs
ARI = 0.27, in particularly because it captures the 4-
cluster deeper in the HC tree (Additional file 1: Figure
S3). Naturally, when the clusters are very heterogenous,
as in scenario 3, both methods perform poorly, which is a
consequence of the HC tree not being able to group sam-
ples from the same true clusters (Additional file 1: Figure
S4). Yet, piecewise snipping performs somewhat better
(ARI = 0.12 vs ARI = 0.09). Hence, we conclude that the
cost of generating the complete search space for piecewise
snipping as opposed to the limited search space for fixed-
height cut is definitely offset by the superior performance
of the former.
Discussion and conclusion
We introduced a novel HC tree snipping method called
guided piecewise snipping, which uses molecular data and
available follow-up information to induce optimal snip-
ping point(s) in the HC tree. Guided piecewise snipping
features a number of novelties and advantages when com-
pared to existing approaches. First, unlike other piecewise
snipping methods our approach is able to deal with (pos-
sibly censored) time-to-event data like survival or relapse.
Second, our bivariate rather than commonly used univari-
ate evaluation of partitions forces the resulting clusters to
be both stable in the molecular data space and associative
in the clinical response space. Third, we demonstrated the
superiority of semi-supervised piecewise snipping over
more conventional semi-supervised fixed-height cuts in
terms of significant associations of (sub-)clusters with
follow-up that were not detected by the fixed-height cut.
Note that even when the piecewise snipping renders the
same result as the fixed-height cut, our approach is use-
ful in the sense that it objectively decides where to snip.
Finally, we introduced PNN+Concordance as a new test-
sample cluster assignment. We showed superior perfor-
mance with respect to Ward-linkage-based assignment
when the association between the molecular data and
clinical response is strong. Note that the latter is the rel-
evant situation for our method: if this association is not
significant then the snipping may not be effective. Hence,
it may be useful to apply the global test [16] as a pre-test
to decide about using supervised snipping or not.
We emphasize that our ambition is to find meaningful
clusters rather than true clusters. In general ‘true clusters’
are unlikely to exist as such: at best, clusters are a discrete
approximation of a more continuous truth. How ‘true’ a
partition is, depends on the context: for treatment options
two clustersmay be very different, whereas from a survival
perspective they may be very similar. Also, note that cur-
rent subtypes are always based on particular choices of the
distance metric and linkage method used; it is well-known
that other choices would have lead to different partitions,
and hence different subtypes.
The guided piecewise snipping differs fundamentally
from supervised prediction (survival prediction, classifi-
cation) methods, in its approach, in its goal and in its
application. First of all, the roles of molecular and time-
to-event data are reversed: supervised prediction centers
around the latter and uses the molecular to issue a pre-
diction; our approach uses time-to-event data to guide
‘prediction’ of molecular subgroups. In addition, unlike
many supervised prediction methods, our approach is
fundamentally non-linear in the molecular space. Our aim
is similar to conventional unsupervised clustering: find
good subgroups of patients rather than a good overall
prediction of time-to-event follow-up. Since the cluster
extraction process is guided by time-to-event data, we
may isolate subgroups that are rather deep in the HC tree,
so the molecular differences with their neighbours are
subtle but apparently relevant for, f.e., survival (Additional
file 1: Figure S28). Finally, note that, unlike the results
of supervised prediction, our result, the subgroups, may
assist in better understanding of the molecular taxonomy
of the disease under study.
There are a number of extensions that may be incorpo-
rated in future versions of this methodology. For example,
from a HC tree one may obtain the height information at
which two clusters are merged. A small incremental value
denotes that there is strong evidence in the data that two
clusters are similar. Incorporating this information into
the partition evaluation process by giving higher scores
to partitions in which clusters are composed of samples
that are merged at comparatively lower height differences
is a interesting line of research. Throughout this study,
we use patient time-to-event follow-up data as clinical
data to identify biologically and clinically meaningful clus-
ters. However, other clinical variables, such as the stage of
tumor, tumor remission status andmetastasis information
etc., may also be used. One only needs to adapt the cluster
quality measure suitable for the data at hand. For example,
suppose we are given binary tumour remission status and
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wish to identify a partition in which clusters are strongly
associated with remission status. In this case, one may use
the in-group proportion criteria [18] to select the optimal
partition.
Methods
Our guided piecewise snipping approach is composed
of three steps to tease out meaningful clusters from a
given HC tree (Figure 6). In this section, we present a
brief description of each step, which also provides the
partial backdrop of our motivations for this work. More
details, also on the use of the algorithm, are given in the
Additional file 1.
The HC tree construction
While our method applies to any distance metric and
linkage method, we base all examples on the Pearson cor-
relation as a distance measure andWard’sminimum vari-
ance as a linkage measure to avoid tuning of the results.
An exception is the Glioblastoma data set (DNA copy
number) for which the distance matrix is calculated by
the dedicated R-package WECCA [19] with parameters
“ordinal” and “heterogeneity”. We assume that the given
HC tree well expresses the similarity between samples in
terms of their molecular profiles. Applying feature selec-
tion may improve the quality of the tree, but to avoid bias
to a particular feature selection technique, we used a full
set of features in all data sets. The evaluation of the opti-
mality of the particular distance metric or linkage method
that optimal for the data set at hand is beyond the scope
of this study.
The search space construction
For guided piecewise snipping, the search space is com-
posed of all possible partitions that can be extracted from
the given HC tree. The size of the search space depends
on the number of samples in the data and the level of
skewness of the HC tree. A balanced tree produces more
partitions than a skewed one. We develop an efficient
algorithm to extract the complete set of partitions from
a HC tree in acceptable time (see the Additional file 1).
For example, the largest data set we used in our analysis is
the Prostate cancer data set [7] (Table 1), which consists
of measurements from 281 patients. Our algorithm took
about three minutes to extract 70910 possible partitions
on a normal dual core CPU 3.16GHz, 4GB of RAM desk-
top computer. To reduce the effect of outliers, and ensure
that the quality of clusters is reliably estimated in a later
stage, we set a threshold on the minimum number of sam-
ples (set to 4 in all data sets) in each cluster. For a very large
data set, this is beneficial as it obviates the need to a assess
large number of trivial partitions (which encompass too
many tiny clusters). Particularly, if one has prior knowl-
edge of an (approximate) upper (or lower) bound for the
cluster size, the constraint placed on the size of clusters
may exclude partitions that deviate too much from one’s
expectation. Extensive experiments with real-world data
sets show that the minimum cluster size in the optimal
partition is often not bounded by the threshold.
For the fixed-height cut, the search space is much
smaller: it consists only of those partitions that results
from cutting the HC at a fixed height. This constitutes
the main difference between the fixed-height cut and
piecewise snipping.
Partition evaluation
The aim of clustering is to uncover meaningful groups in
the data. However, not any arbitrary partitioning of a given
data set reflects such structure. Upon obtaining the com-
plete set of partitions from a givenHC tree, the next step is
to evaluate each partition objectively and select the opti-
mal one among a large number of candidates. The selected
partition should unravel the hidden data structure and
should be stable enough to extrapolate to new samples.
A cluster quality measure is a function that, given a data
set and its partition into clusters, returns a real number
representing how strong or conclusive the clustering is.
Existing approaches allow for evaluating a partition either
using molecular data alone, or only using follow-up infor-
mation (which is required to be in discrete format). In
order to obtain a robust clustering and represent the data
structure in both data spaces, we propose the following
strategy, depicted in Figure 6:
1. Evaluate partitions using molecular data alone (call it
scorem). Given the number of cluster quality
measures exist, it is infeasible to explore all in our
application. Refer to [20] for a overview of existing
cluster quality measures. In this work we mainly
focus on the Within-cluster-Sum-of-Square (WSS);
results for alternative measures like the C-index and
Goodman-Kruskal index (GK) were qualitatively very
similar. For a given partition and corresponding
distance matrix, we calculate an overall quality score
using one of these measures.
2. Evaluate partitions using follow-up data alone (call it
scores). Here, we use the cluster labels in each
partition as a covariate and time-to-event data as
response variable to assess their association. We
apply a measure tailored to time-to-event task:
modified AIC [21]. Unlike p-values, this criterion
allows comparison across partitions that include
different number of clusters. Qualitatively, use of
ordinary AIC and (modified) BIC [22] do often not
lead to considerable differences.
3. Rank scorem and scores across partitions from good
to bad, separately. The final evaluation score of each
partition is the summation of the two ranking values
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Figure 6 The work flow of the piecewise snipping approach.
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(call it scorems). A partition with the smallest scorems
is selected as the optimal clustering. Our motivation
to use ranks rather than scorem and scores directly is
that the latter two are on very different scales,
whereas the ranks are on the same scale, thus
suitable for adding.
The criteria above also apply to partitions created by
guided fixed-height cutting, hence this differs from guided
piecewise snipping only by the size of the search space.
The illustrations in the Results section show that the supe-
rior performance of our approach is not an artifact of the
larger search space induced by piecewise snipping: the
superior performance remains when evaluated on inde-
pendent test samples on a variety of cancer molecular data
sets. Note that the choice of cluster quality measures and
information criteria is free. In our flexible implementation
one can directly insert the alternatives mentioned above
and ones own metrics as well.
Clustering on the test set
To estimate and compare performances of the guided
piecewise snipping and the fixed-height cut approaches in
an unbiased manner, we perform 3-fold cross-validation
(3CV) to split the data three times into non-overlapping
training and test sets, such that each sample belongs to
the test set exactly once. For a given split, an optimal
partition is derived using the training set, then each test
sample is assigned to one of the clusters in the optimal
partition. Note that, for the test set, we assume that the
patient time-to-event information is not available. If the
clustering found in the training phase is “good” enough
to represent the hidden data structure, then we expect
relatively high-quality clustering on the test set.
The Ward distance metric used to construct in the
HC tree, may also be used to assign cluster labels of the
optimal partition found in the training phase to the test
samples. But, we have to keep in mind that, the nature
of the purposed approach here is semi-supervised clus-
tering. The Ward distance simply assigns a test sample
to a particular cluster based only on the similarity of
their molecular profiles. However, due to noisy nature of
molecular data, the observed molecular profile of a sam-
ple may appear to be more similar to members of a cluster
that differ considerably in terms of their time-to-event
information. Like in the training phase, clustering on the
test set should, ideally, also take into account the similari-
ties between samples both in the molecular and follow-up
data spaces. Since we assume that the latter is not available
for the test set, we decide to make use of a novel distance
metric based on an indirect projection principle, termed
PNN+Concordance [23].
The PNN+Concordance (PNNC) approach works as fol-
lows: first, it determines a test sample’s nearest neighbours
(NN) in the molecular data space of the training set, sub-
sequently the pseudo nearest neighbours [23] (PNN) in
the time-to-event data space. The PNN of the test sam-
ple are determined by considering the projection of the
NNs onto the time-to-event space, as well as the neigh-
bours of the NN in this space. PNNC uses Harrel’s concor-
dance index [24] to decide the similarity between PNN
and members of a cluster under consideration. For
the sake of comparison, we present the results from
both Ward and PNNC. A detailed description of the
PNN+Concordance approach, including a toy example, is
given in the Additional file 1.
Validation
We validate the two approaches using a statistical test-
ing perspective. For a given split of the data, the testing
perspective is simple: we assign test samples to the clus-
ters (as created by either the guided piecewise snipping
or the fixed-height cut) and test the null-hypothesis that
the clusters to which the test subjects are assigned are
independent of the actual survival times of those sub-
jects. To this end, we apply a log-rank test. For each of
the three splits (when using 3CV), the test renders one
p-value that represents how well the clustering resulting
from the training data discriminates (new) samples with
respect to the time-to-event (survival) data. Note that the
resulting p-values are not independent due to the overlap
between training samples in one split and test samples in
another. The median of the three p-values, however, is a
valid measure of significance [25].
Availability and requirements
• Project name: HCsnip
• Project home page: http://www.bioconductor.org/
packages/release/bioc/html/HCsnip.html
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• Programming language: R
• Licence: General Public Licence (≥ 2)
Endnotes
1Bias adjusted p-value obtained by permutation. See
the Additional file 1.
Additional file
Additional file 1: Supplementary Document. This document provides
the detailed description of the piecewise snipping algorithm, and some
results not included in the paper.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AO developed methodology, performed data analysis, wrote the R package
and the manuscript. GAM conceived this study and critically revised the
manuscript. MAW conceived this study, developed methodology and critically
revised the manuscript. All authors read and approved the manuscript.
Obulkasim et al. BMC Bioinformatics  (2015) 16:15 Page 11 of 11
Acknowledgements
This study was performed within the framework of the Center for Translational
Molecular Medicine, DeCoDe project (grant 03O-101).
Author details
1Department of Epidemiology and Biostatistics, VU University Medical Center,
Amsterdam, The Netherlands. 2Department of Pathology, VU University
Medical Center, Amsterdam, The Netherlands. 3Department of Mathematics,
VU University, Amsterdam, The Netherlands.
Received: 20 October 2014 Accepted: 17 November 2014
References
1. de Souto M, Costa IG, de Araujo D, Ludermir TB, Schliep A. Clustering
cancer gene expression data: a comparative study. BMC Bioinformatics
2008;9:497.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick
JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson
JJ, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC,
Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever
MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse
large B-cell lymphoma identified by gene expression profiling. Nature
2000;403(6769):503–511.
3. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C,
Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES,
Wong W, Johnson BE, Golub TR, Sugarbaker DJ MM. Classification of
human lung carcinomas by mRNA expression profiling reveals distinct
adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98(24):
13790–13795.
4. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T,
Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC,
Brown PO, Botstein D, Lønning PE, Børresen-Dale AL. Gene expression
patterns of breast carcinomas distinguish tumor subclasses with clinical
implications. Proc Natl Acad Sci USA 2001;98(19):10869–10874.
5. Beer DG, Kardia SLR, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L,
Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor
JMG, Iannettoni MD, Orringer MB. Gene-expression profiles predict
survival of patients with lung adenocarcinoma. Nature 2002;8(8):816–824.
6. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical
cluster tree: the Dynamic Tree Cut package for R. Bioinformatics
2008;24(5):719–720.
7. Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, Hoshida Y, Perner
S, Adami HO, Fall K, Mucci LA, Kantoff11 WP, Stampfer M, Andersson
SO, Varenhorst E, Johansson10 JE, Gerstein MB, Golub TR, Rubin MA,
Andrén O. Molecular sampling of prostate cancer: a dilemma for
predicting disease progression. BMC Med Genomics 2010;3:8.
8. Bair E, R T. Semi-supervised methods to predict patient survival from gene
expression data. PLoS Biol 2004;2(4):511–522.
9. Ward JHJ. Hierarchical grouping to optimize an objective function.
J Am Statist Assoc 1963;58(301):236–244.
10. Dotan-Cohen D, Melkman AA, Kasif S. Hierarchical tree snipping
clustering guided by prior knowledge. Bioinformatics 2007;23(24):
3335–3342.
11. Kustra R, Zagdan´ski A. Incorporating gene ontology in clustering gene
expression data. In: CBMS ’06 Proceedings of the 19th IEEE Symposium on
Computer-Based Medical Systems Salt Lake City, UT. IEEE; 2006. p.
555–563.
12. Ideker T, Dutkowski J, L H. Boosting signal-to-noise in complex biology:
prior knowledge is power. Cell 2011;144(6):860–863.
13. Navlakha S, White J, Nagarajan N, Pop M, Kingsford C. Finding
biologically accurate clusterings in hierarchical tree decompositions
using the variation of information. J Comp Biol 2010;17(3):503–516.
14. Bayá AE, Granitto PM. Clustering gene expression data with a penalized
graph-based metric. BMC Bioinformatics 2011;12:2.
15. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous
predictors in multiple regression: a bad idea. Stat Med 2006;25:127–141.
16. Goeman JJ, van de Geer SA, De Kort F, van Houwelingen HC. A global
test for groups of genes: testing association with a clinical outcome.
Bioinformatics 2004;20:93–99.
17. van Wieringen WN, van der Vaart AW. Statistical analysis of the cancer
cells molecular entropy using high-throughput data. Bioinformatics
2010;27(4):556–563.
18. Kapp AV, Tibshirani R. Are clusters found in one dataset present in
another dataset? Biostat 2007;8:9–31.
19. van Wieringen WN, van de Wiel MA, Ylstra B. Weighted clustering of
array CGH data. Biostat 2008;9(3):484–500.
20. Milligan GW. A Monte-Carlo study of 30 internal criterion measures for
cluster-analysis. Psychometrica 1981;46(2):187–195.
21. Liang H, Zou G. Improved AIC selection strategy for survival analysis.
Comput Stat Anal 2008;52(5):2538–2548.
22. Volinsky TC, E RA. Baysian information criteria for censored survival
models. Biometrics 2000;56:256–262.
23. Obulkasim A, Meijer GA, van de Wiel MA. Stepwise classification of
cancer samples using clinical and molecular data. BMC Bioinformatics
2011;12:422.
24. Harrell FEJ, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of
medical tests. JAMA 1982;247(18):2543–2546.
25. Van de Wiel MA, Berkhof J, van Wieringen WN. Testing the prediction
error difference between 2 predictors. Biostatistics 2009;10:550–560.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
